Seizures Clinical Trials

Find Seizures Clinical Trials Near You

Critical Care Optimized Pediatric Quantitative EEG

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

The detection and appropriate treatment of seizures significantly impact the neurological prognosis of patients in intensive care. Indeed, altered brain function including seizures is described in critically ill children, regardless of the reason for admission. Most seizures are subclinical and therefore impossible to diagnose without neuromonitoring tools. Despite being concidered ad Gold Standard, continuous EEG (cEEG) with video recording shows difficulty of implementation and interpretation at all hours of the day and night explaining that less than 10% of centers in France use cEEG routinely. Most departments prefer simplified techniques, including amplitude traces (aEEG) which can be used continuously at the bedside. However, the positive predictive value of aEEG in the detection of seizures does not exceed 78% and 64% in newborns and children respectively making necessary an optimization of the information provided by these techniques. This project is a pragmatic diagnostic study that aims at developing and evaluating a neuromonitoring interface adapted to the needs of pediatric and neonatal intensive care units and meeting the requirements of neurophysiologists in terms of EEG trace quality.

Eligibility
Participation Requirements
Sex: All
Maximum Age: 2
Healthy Volunteers: f
View:

• Patients younger than 2 years old hospitalized in the intensive care unit with an indication for neuromonitoring. The same patient may be included multiple times.

• Written non-opposition from legal representatives.

• Patients affiliated with or beneficiaries of a social security or similar scheme (CMU).

Locations
Other Locations
France
CHU de Nantes
RECRUITING
Nantes
Contact Information
Primary
Noura ZAYAT, PH
noura.zayat@chu-nantes.fr
33 2 76 64 37 91
Backup
Pierre BOURGOIN, PH
pierre.bourgoin@chu-nantes.fr
33 2 76 64 36 12
Time Frame
Start Date: 2025-09-16
Estimated Completion Date: 2027-09-16
Participants
Target number of participants: 120
Related Therapeutic Areas
Sponsors
Leads: Nantes University Hospital

This content was sourced from clinicaltrials.gov